Organization
Ontario Clinical Oncology Group
4 clinical trials
1 abstract
Clinical trial
Randomized Trial of Epoetin Alfa in Patients With Advanced Non-Small Cell Carcinoma of the Lung (EPO-CAN-20)Status: Terminated
Clinical trial
Cytoreductive Stereotactic Hypofractionated Radiotherapy With Combination Ipilimumab/Nivolumab for Metastatic Kidney CancerStatus: Active (not recruiting), Estimated PCD: 2024-03-31
Clinical trial
Neoadjuvant Combination of Atezolizumab/Bevacizumab Versus Neoadjuvant Radiation Therapy Prior to Hepatectomy in Hepatocellular Carcinoma With Portal Vein Tumour Thrombus (ADVANCE HCC) Hoffmann La Roche Protocol Number: ML42525Status: Recruiting, Estimated PCD: 2026-06-30
Clinical trial
A Study of Elranatamab Management With Outpatient and Intermittent Dosing in Relapsed/Refractory Multiple MyelomaStatus: Not yet recruiting, Estimated PCD: 2025-12-01
Abstract
Use of prophylactic and reactive feeding tubes in patients with esophageal cancer: A single-centre cohort study.Org: Ontario Clinical Oncology Group, McMaster University and Juravinski Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto,